| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/28/2009 | CA2399209C Process for preparation of indolopyrrolocarbazole derivative, intermediates in the preparation and process for preparation of the intermediates |
| 07/28/2009 | CA2377174C Oral administration forms for administering a fixed tramadol and diclofenac combination |
| 07/28/2009 | CA2370147C Piperidine-indole compounds having 5-ht6 affinity |
| 07/28/2009 | CA2366996C Ascorbic acid composition and method for treatment of aging or damaged skin |
| 07/28/2009 | CA2354574C Troxerutin with high trihydroxy-ethyl-rutin content and method for preparing same |
| 07/28/2009 | CA2315235C Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same |
| 07/28/2009 | CA2304899C New use of selective serotonin reuptake inhibitors for treatment of human patients with chest pain of non-cardiac origin or with gastro-esophageal reflux disease |
| 07/28/2009 | CA2255804C Antitumoral method by administration of partricin derivatives |
| 07/28/2009 | CA2245370C Production of pharmaceutical formulations for treatment of edema and venous disorders |
| 07/23/2009 | WO2009092050A2 Pterin based therapies for inflammatory conditions |
| 07/23/2009 | WO2009091986A1 Use of proton pump inhibitors as drug delivery adjuvants |
| 07/23/2009 | WO2009091982A1 Mir-122 agonist |
| 07/23/2009 | WO2009091967A2 Fenofibric acid polymorphs; methods of making; and methods of use thereof |
| 07/23/2009 | WO2009091964A2 Method for treating addiction using quercetin-containing compositions |
| 07/23/2009 | WO2009091941A1 Small molecule inhibitors of hiv proteases |
| 07/23/2009 | WO2009091939A1 Imidazopyrazinol derivatives for the treatment of cancers |
| 07/23/2009 | WO2009091932A2 Treatment of mild dementia of the alzheimer's disease type |
| 07/23/2009 | WO2009091921A1 Synthesis of resorcylic acid lactones useful as therapeutic agents |
| 07/23/2009 | WO2009091898A2 6-and 7-amino isoquinoline compounds and methods for making and using the same |
| 07/23/2009 | WO2009091889A1 Treatment of skin disorders with egfr inhibitors |
| 07/23/2009 | WO2009091874A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | WO2009091831A1 Compound forms and uses thereof |
| 07/23/2009 | WO2009091813A1 Compounds useful as alpha7 nicotinic acetylcholine receptor agonists |
| 07/23/2009 | WO2009091788A1 3h-[1,2,3]triazolo[4,5-d]pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 07/23/2009 | WO2009091765A1 Therapeutic compounds |
| 07/23/2009 | WO2009091764A2 Beta-lactams for the treatment of glaucoma, ocular hypertension, baldness and hair loss |
| 07/23/2009 | WO2009091760A1 Oxazolidine and thiazolidine selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | WO2009091759A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | WO2009091735A1 Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/23/2009 | WO2009091634A1 Crystalline 2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide |
| 07/23/2009 | WO2009091622A1 Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol |
| 07/23/2009 | WO2009091605A2 Taste titration therapies |
| 07/23/2009 | WO2009091594A1 Crystalline forms of lestaurtinib |
| 07/23/2009 | WO2009091576A2 Parenteral formulations of dopamine agonists |
| 07/23/2009 | WO2009091561A1 Preparation and enantiomeric separation of 7-(3-pyridinyl)-1,7-diazaspiro[4.4] nonane and novel salt forms of the racemate and enantiomers |
| 07/23/2009 | WO2009091549A1 Modified starch material of biocompatible hemostasis |
| 07/23/2009 | WO2009091546A1 Anesthetic compounds |
| 07/23/2009 | WO2009091538A2 Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia |
| 07/23/2009 | WO2009091476A1 Compositions and methods for treating cancers |
| 07/23/2009 | WO2009091435A2 Methods of inhibiting viral infection |
| 07/23/2009 | WO2009091433A2 Spiro and dispiro 1,2,4-trioxolane antimalarials |
| 07/23/2009 | WO2009091374A2 Fused heterocyclic derivatives and methods of use as c-met inhibitors |
| 07/23/2009 | WO2009091346A2 Stable pharmaceutical formulation and preparation methods |
| 07/23/2009 | WO2009091324A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| 07/23/2009 | WO2009091291A1 N-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-5h-pyrimidinesulfone)-isonicotinoyl hydrazide silver salt |
| 07/23/2009 | WO2009091134A2 Pharmaceutical composition for sepsis and septic shock |
| 07/23/2009 | WO2009091082A1 Combination therapy comprising sglt inhibitors and dpp4 inhibitors |
| 07/23/2009 | WO2009091017A1 Stable pharmaceutical composition |
| 07/23/2009 | WO2009091016A1 Condensed aminodihydrothiazine derivative |
| 07/23/2009 | WO2009091014A1 Phenyl acetamide derivative |
| 07/23/2009 | WO2009090976A1 Transmucosal therapeutic preparation for nasal obstruction |
| 07/23/2009 | WO2009090970A1 Liver function-protecting agent |
| 07/23/2009 | WO2009090950A1 Chitosan-containing compositions and process for production thereof |
| 07/23/2009 | WO2009090903A1 Platinum complex compound and utilization of the same |
| 07/23/2009 | WO2009090679A1 Use of acyclovir for the treatment of condylomatosis |
| 07/23/2009 | WO2009090661A1 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders |
| 07/23/2009 | WO2009090648A2 Use of antimicrobial polymers for re-sensitization of microorganisms upon emergence of resistance to anti-microbial agents |
| 07/23/2009 | WO2009090623A1 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological applications thereof |
| 07/23/2009 | WO2009090614A2 Derivatives of taxol and closely related compounds |
| 07/23/2009 | WO2009090558A2 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| 07/23/2009 | WO2009090556A2 Artificial reproduction of pharmaceutical conditions of dependency to tobacco and other addictive drugs (opiacea, psychostimulants, alcohol) by combination of nicotine and a ligand (agonist or 5 antagonist) of 5-ht1a receptors |
| 07/23/2009 | WO2009090484A2 Mesalazine tablet |
| 07/23/2009 | WO2009090431A1 Cyclic triazo and diazo sodium channel blockers |
| 07/23/2009 | WO2009090414A1 Compounds having crth2 antagonist activity |
| 07/23/2009 | WO2009090399A1 Indoles active on crth2 receptor |
| 07/23/2009 | WO2009090251A2 Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentan0ic acid derivatives |
| 07/23/2009 | WO2009090239A1 Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 07/23/2009 | WO2009090222A1 Naphthyridin-2(1h) -one compounds useful as antibacterials |
| 07/23/2009 | WO2009090210A2 Combination of metformin and an mtp inhibitor |
| 07/23/2009 | WO2009090202A1 Monomaleate monohydrate salt of a 5ht1a receptor antagonist |
| 07/23/2009 | WO2009090189A1 Powdered protein compositions and methods of making same |
| 07/23/2009 | WO2009090177A1 Bifeprunox derivatives |
| 07/23/2009 | WO2009090173A1 Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/23/2009 | WO2009090158A1 Atorvastatin-aliskiren |
| 07/23/2009 | WO2009090085A1 Abnormal intraocular pressure treatment |
| 07/23/2009 | WO2009090081A1 Tetrahydropyridoethers for treatment of amd |
| 07/23/2009 | WO2009090063A1 Steroid sapogenin, androstane and triterpenoid sapogenin derivatives for the treatment and prevention of infectious diseases |
| 07/23/2009 | WO2009090055A1 Substituted sulfonamide derivatives |
| 07/23/2009 | WO2009090054A1 Substituted sulfonamide derivatives |
| 07/23/2009 | WO2009090024A1 Solid forms of ortataxel |
| 07/23/2009 | WO2009090023A1 Crystalline form i of ortataxel |
| 07/23/2009 | WO2009090009A1 Pharmaceutical formulation comprising an anticholinergic drug |
| 07/23/2009 | WO2009090008A1 Dry powder formulation comprising an anticholinergic drug |
| 07/23/2009 | WO2009089975A1 Food composition |
| 07/23/2009 | WO2009089974A1 Food composition |
| 07/23/2009 | WO2009089900A1 Treatment of colon diseases or prevention of colorectal carcinoma with imidazoquinoline derivatives |
| 07/23/2009 | WO2009089889A1 Use of isothiocyanate derivatives as anti-myeloma agents |
| 07/23/2009 | WO2009089880A1 Preparation containing chromane-2-one derivatives |
| 07/23/2009 | WO2009089851A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments |
| 07/23/2009 | WO2009089845A1 Agent for intra-articular injection |
| 07/23/2009 | WO2009089826A1 Benzodiazepine and/or pharmaceutical composition comprising benzodiazapine derivatives |
| 07/23/2009 | WO2009089804A1 Novel cytostatic 7-deazapurine nucleosides |
| 07/23/2009 | WO2009089702A1 Stable 6-methoxy-2',3'-dideoxyguanosine, method for preparing the same and pharmaceutical composition containing the same |
| 07/23/2009 | WO2009089680A1 Method of modulating membrane potential of a cell |
| 07/23/2009 | WO2009089659A1 Pyrollidine-based compounds |
| 07/23/2009 | WO2009089632A1 Implantable devices for promoting reendothelialization and methods of use thereof |
| 07/23/2009 | WO2009073575A3 Methods for treating induced cellular proliferative disorders |
| 07/23/2009 | WO2009071725A3 Use of valproate for the treatment of fear and phobia in subjects with alzheimer's disease |
| 07/23/2009 | WO2009071690A3 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| 07/23/2009 | WO2009071689A3 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |